Active Not Recruiting OBSERVATIONAL NCT06728319
A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World (CLARIFY)
Sponsor: Biodesix, Inc.
Conditions
Lung Nodules
Updated 2 times since 2025 Last updated: Feb 6, 2025 Started: Sep 19, 2024 Primary completion: Jul 31, 2026 Completion: Jul 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Lung Nodules and is currently ongoing. Biodesix, Inc. leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
2 versions recorded-
Mar 2025 — Present [monthly]
Active Not Recruiting
-
Jan 2025 — Mar 2025 [monthly]
Active Not Recruiting
First recorded
Sep 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Biodesix, Inc.
Data source: Biodesix, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .